A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, with Axillary Hyperhidrosis

Main Article Content

Brandon Kirsch
Janet DuBois
Deepak Chadha


hyperhidrosis, axillary, sofpironium bromide, children, adolescents, pharmokinetics


Abstract not available.


1. Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis; an update on prevalence and severity in the United States. Arch Dermatol Res. 2016; 308:743-749.

Most read articles by the same author(s)